129 related articles for article (PubMed ID: 29521196)
1. The Significance of Oxidized Low-Density Lipoprotein in Body Fluids as a Marker Related to Diseased Conditions.
Itabe H; Kato R; Sawada N; Obama T; Yamamoto M
Curr Med Chem; 2019; 26(9):1576-1593. PubMed ID: 29521196
[TBL] [Abstract][Full Text] [Related]
2. The apolipoprotein B concentration in gingival crevicular fluid increases in patients with diabetes mellitus.
Noguchi E; Kato R; Ohno K; Mitsui A; Obama T; Hirano T; Itabe H; Yamamoto M
Clin Biochem; 2014 Jan; 47(1-2):67-71. PubMed ID: 24095848
[TBL] [Abstract][Full Text] [Related]
3. Detection of oxidized low-density lipoproteins in gingival crevicular fluid from dental patients.
Sakiyama Y; Kato R; Inoue S; Suzuki K; Itabe H; Yamamoto M
J Periodontal Res; 2010 Apr; 45(2):216-22. PubMed ID: 19778326
[TBL] [Abstract][Full Text] [Related]
4. Locally produced anti-phosphorylcholine and anti-oxidized low-density lipoprotein antibodies in gingival crevicular fluid from aggressive periodontitis patients.
Schenkein HA; Berry CR; Burmeister JA; Brooks CN; Best AM; Tew JG
J Periodontol; 2004 Jan; 75(1):146-53. PubMed ID: 15025226
[TBL] [Abstract][Full Text] [Related]
5. Changes in apolipoprotein B and oxidized low-density lipoprotein levels in gingival crevicular fluids as a result of periodontal tissue conditions.
Ishizuka M; Kato R; Moriya Y; Noguchi E; Koide Y; Inoue S; Itabe H; Yamamoto M
J Periodontal Res; 2017 Jun; 52(3):594-602. PubMed ID: 28233905
[TBL] [Abstract][Full Text] [Related]
6. The etiological consideration of oxidized low-density lipoprotein in periodontitis.
Yamamoto M; Sugano M; Itabe H
J Oral Biosci; 2023 Mar; 65(1):19-23. PubMed ID: 36206991
[TBL] [Abstract][Full Text] [Related]
7. Oxidized-low density lipoprotein in gingival crevicular fluid of patients with chronic periodontitis: a possible link to atherogenesis.
Shah R; Thomas R; Mehta DS
Acta Odontol Scand; 2014 Feb; 72(2):154-6. PubMed ID: 23822906
[TBL] [Abstract][Full Text] [Related]
8. [Atherosclerosis and sensitive determination of oxidized LDL using monoclonal antibody].
Itabe H
Yakugaku Zasshi; 2002 Oct; 122(10):745-53. PubMed ID: 12400156
[TBL] [Abstract][Full Text] [Related]
9. Oxidative modification of LDL: its pathological role in atherosclerosis.
Itabe H
Clin Rev Allergy Immunol; 2009 Aug; 37(1):4-11. PubMed ID: 18987785
[TBL] [Abstract][Full Text] [Related]
10. Sensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibody.
Itabe H; Yamamoto H; Imanaka T; Shimamura K; Uchiyama H; Kimura J; Sanaka T; Hata Y; Takano T
J Lipid Res; 1996 Jan; 37(1):45-53. PubMed ID: 8820101
[TBL] [Abstract][Full Text] [Related]
11. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
Ishigaki Y; Katagiri H; Gao J; Yamada T; Imai J; Uno K; Hasegawa Y; Kaneko K; Ogihara T; Ishihara H; Sato Y; Takikawa K; Nishimichi N; Matsuda H; Sawamura T; Oka Y
Circulation; 2008 Jul; 118(1):75-83. PubMed ID: 18559699
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of oxidized low-density lipoprotein and impaired nocturnal synthesis of melatonin in patients with myocardial infarction.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez M; Ferrer-Hita J; Vargas M; Reiter RJ
Atherosclerosis; 2005 May; 180(1):101-5. PubMed ID: 15823281
[TBL] [Abstract][Full Text] [Related]
13. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients?
Pawlak K; Mysliwiec M; Pawlak D
Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
15. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit.
Boyd HC; Gown AM; Wolfbauer G; Chait A
Am J Pathol; 1989 Nov; 135(5):815-25. PubMed ID: 2683796
[TBL] [Abstract][Full Text] [Related]
16. Circulating oxidized LDL, increased in patients with acute myocardial infarction, is accompanied by heavily modified HDL.
Sawada N; Obama T; Koba S; Takaki T; Iwamoto S; Aiuchi T; Kato R; Kikuchi M; Hamazaki Y; Itabe H
J Lipid Res; 2020 Jun; 61(6):816-829. PubMed ID: 32291330
[TBL] [Abstract][Full Text] [Related]
17. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.
Trpkovic A; Resanovic I; Stanimirovic J; Radak D; Mousa SA; Cenic-Milosevic D; Jevremovic D; Isenovic ER
Crit Rev Clin Lab Sci; 2015; 52(2):70-85. PubMed ID: 25537066
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylcholine and phosphatidylethanolamine plasmalogens in lipid loaded human macrophages.
Wallner S; Orsó E; Grandl M; Konovalova T; Liebisch G; Schmitz G
PLoS One; 2018; 13(10):e0205706. PubMed ID: 30308051
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal accumulation of oxidized phosphatidylcholine-apolipoprotein B complex in macrophages: intracellular fate of oxidized low density lipoprotein.
Itabe H; Suzuki K; Tsukamoto Y; Komatsu R; Ueda M; Mori M; Higashi Y; Takano T
Biochim Biophys Acta; 2000 Sep; 1487(2-3):233-45. PubMed ID: 11018475
[TBL] [Abstract][Full Text] [Related]
20. Beyond LDL-c: The importance of serum oxidized LDL in predicting risk for type 2 diabetes in the middle-aged Asian Indians.
Banerjee J; Mishra N; Damle G; Dhas Y
Diabetes Metab Syndr; 2019; 13(1):206-213. PubMed ID: 30641698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
